Most common Oncology denials
Denials you probably recognize
Chemotherapy regimen denied as not first-line
PET scan denied for surveillance
Immunotherapy denied -- biomarker criteria not met
Genetic testing denied as not medically necessary
Proton beam therapy denied -- conventional radiation preferred
Sound familiar? WinTheP2P generates a structured response script for each of these scenarios in 60 seconds.
Oncology-specific P2P strategy
What wins oncology P2P calls
Reference NCCN guidelines with specific pathway and category of evidence
For off-label use, cite peer-reviewed studies and compendia listings
Emphasize urgency -- treatment delays in oncology have measurable survival impact
Document why standard regimens are contraindicated for this patient
For immunotherapy, present biomarker results (PD-L1, MSI-H, TMB) with lab reports
Key criteria sources
Guidelines that matter for Oncology
When speaking with a medical director during a P2P call, referencing the correct clinical criteria is what separates a successful appeal from a denied one. For oncology, the key sources are:
NCCN Guidelines, FDA Compendia, Peer-Reviewed Literature
WinTheP2P automatically references these criteria when generating your oncology P2P prep scripts.